Physician profile
Flora Kim
NPI 1699905372
$2,041.80
in general payments reported to CMS, 2019-2025
23 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $185 · 2021: $267 · 2022: $119 · 2023: $145 · 2024: $104 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $367.60 | 2019-2021 | |
| Allergan, INC. | $291.36 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $270.48 | 2019-2022 | |
| Galderma Laboratories, L.P. | $245.66 | 2019-2021 | |
| Abbvie INC. | $170.79 | 2019-2025 | |
| Revance Therapeutics, INC. | $154.19 | 2024-2025 | Daxxify |
| Sientra, INC. | $100.58 | 2019 | |
| Janssen Biotech, INC. | $59.36 | 2022 | |
| Biofrontera INC. | $44.87 | 2019-2020 | |
| Medimetriks Pharmaceuticals, INC. | $43.31 | 2019-2023 | |
| Almirall LLC | $41.57 | 2019-2023 | Klisyri |
| Amgen INC. | $40.68 | 2019-2021 | |
| Tactile Systems Technology INC | $34.80 | 2019 | |
| Celgene Corporation | $32.31 | 2019 | |
| Epi Health, LLC | $21.68 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $20.68 | 2021 | |
| Genzyme Corporation | $17.51 | 2025 | |
| Leo Pharma INC. | $15.99 | 2019 | |
| Botanix Sb INC | $15.67 | 2025 | Sofdra |
| Dermira, INC. | $15.35 | 2019 | |
| Pfizer INC. | $13.44 | 2019 | |
| Aclaris Therapeutics, INC. | $12.12 | 2019 | |
| Prugen, INC. Pharmaceuticals | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flora Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.